Compare ZBH & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | QXO |
|---|---|---|
| Founded | 1927 | 1988 |
| Country | United States | United States |
| Employees | N/A | 7794 |
| Industry | Industrial Specialties | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 16.3B |
| IPO Year | 2001 | N/A |
| Metric | ZBH | QXO |
|---|---|---|
| Price | $83.38 | $18.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 21 | 14 |
| Target Price | ★ $101.00 | $32.85 |
| AVG Volume (30 Days) | 2.4M | ★ 16.1M |
| Earning Date | 04-28-2026 | 05-08-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $8,231,500,000.00 | N/A |
| Revenue This Year | $4.96 | $70.27 |
| Revenue Next Year | $3.76 | $38.75 |
| P/E Ratio | $68.25 | ★ N/A |
| Revenue Growth | ★ 7.20 | N/A |
| 52 Week Low | $79.83 | $13.72 |
| 52 Week High | $108.29 | $27.61 |
| Indicator | ZBH | QXO |
|---|---|---|
| Relative Strength Index (RSI) | 36.72 | 39.82 |
| Support Level | $79.83 | $18.48 |
| Resistance Level | $96.94 | $20.54 |
| Average True Range (ATR) | 2.56 | 1.18 |
| MACD | -0.77 | -0.29 |
| Stochastic Oscillator | 22.47 | 3.26 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
QXO Inc is a publicly traded distributor of building products in North America. The company is executing its plan to become the tech-enabled leader in the around $800 billion building products distribution industry and generate outsized value for its shareholders. The group expects to achieve its target of nearly $50 billion in annual revenues within the next decade through accretive acquisitions and organic growth.